These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 3706319)
1. Controversies in antimicrobial therapy: pitfalls in monitoring aminoglycoside therapy. Fant WK Am J Hosp Pharm; 1986 Mar; 43(3):641-6. PubMed ID: 3706319 [TBL] [Abstract][Full Text] [Related]
2. Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoring. Croes S; Koop AH; van Gils SA; Neef C Eur J Pharm Sci; 2012 Jan; 45(1-2):90-100. PubMed ID: 22094306 [TBL] [Abstract][Full Text] [Related]
3. [Prediction of aminoglycoside nephrotoxicity]. Lucht F; Peyramond D; Robert D; Vincent P Sem Hop; 1982 Sep; 58(35):2021-5. PubMed ID: 6293091 [TBL] [Abstract][Full Text] [Related]
4. Aminoglycosides: assessing the potential for nephrotoxicity. Wilson SE Surg Gynecol Obstet; 1990; 171 Suppl():24-30. PubMed ID: 2244292 [TBL] [Abstract][Full Text] [Related]
5. Nephrotoxicity of aminoglycosides and cephalosporins in combination. Rankin GO; Sutherland CH Adverse Drug React Acute Poisoning Rev; 1989; 8(2):73-88. PubMed ID: 2672726 [TBL] [Abstract][Full Text] [Related]
6. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing. Dager WE; King JH Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944 [TBL] [Abstract][Full Text] [Related]
8. Aminoglycosides--50 years on. Begg EJ; Barclay ML Br J Clin Pharmacol; 1995 Jun; 39(6):597-603. PubMed ID: 7654476 [TBL] [Abstract][Full Text] [Related]
9. Comparative study of three antimicrobial drugs protocol (Ceftriaxone, Gentamicin/Amikacin and Metronidazole) versus two antimicrobial drugs protocol (Ceftriaxone and Metronidazole) in cases of intra-abdominal sepsis. Khan S; Gupta DK; Khan DN Kathmandu Univ Med J (KUMJ); 2005; 3(1):55-63. PubMed ID: 16401946 [TBL] [Abstract][Full Text] [Related]
10. Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis. Graham AC; Mercier RC; Achusim LE; Pai MP Ann Pharmacother; 2004 Jun; 38(6):936-41. PubMed ID: 15084688 [TBL] [Abstract][Full Text] [Related]
17. Cost analysis of an aminoglycoside pharmacokinetic dosing program. Schloemer JH; Zagozen JJ Am J Hosp Pharm; 1984 Nov; 41(11):2347-51. PubMed ID: 6507436 [TBL] [Abstract][Full Text] [Related]
18. Serum level monitoring of antibacterial drugs. A review. Wenk M; Vozeh S; Follath F Clin Pharmacokinet; 1984; 9(6):475-92. PubMed ID: 6391780 [TBL] [Abstract][Full Text] [Related]
19. Back to the future: using aminoglycosides again and how to dose them optimally. Drusano GL; Ambrose PG; Bhavnani SM; Bertino JS; Nafziger AN; Louie A Clin Infect Dis; 2007 Sep; 45(6):753-60. PubMed ID: 17712761 [TBL] [Abstract][Full Text] [Related]